Negative dromotropism of adenosine under beta-adrenergic stimulation with isoproterenol

Wen Ter Lai, Sheng-Nan Wu, Ruey J. Sung

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Adenosine depresses atrioventricular (AV) nodal function by binding to specific A1 receptors which activate the acetylcholine, adenosine-regulated potassium current. In addition, adenosine can act to antagonize the effects of β-adrenergic stimulation on AV nodal function. To assess the negative dromotropic effects of adenosine under β-adrenergic stimulation, 15 patients were studied during clinical electrophysiologic study. During high right atrial pacing at a cycle length of 400 to 600 ms, adenosine was injected intravenously at an initial dose of 0.5 mg followed by a stepwise increment of 0.5 or 1.0 mg given at 5-minute intervals until a maximal dose of 12 mg was achieved or AV block developed. Intravenous isoproterenol (1 to 3 μg/min) was then infused to accelerate sinus rate by 20 to 30% during which intravenous injection of incremental doses of adenosine as described was repeated. The AV nodal conduction time (AH interval) was measured at each dose of adenosine. Dose-response curves of AV nodal conduction time (expressed as percent increase in AH interval) were studied during the control state and during isoproterenol infusion. The dose of adenosine required to produce AV nodal Wenckebach block, the increase in the AH interval by 50% (ED50) and the maximal response (Emax) were 3.4 ± 0.9 mg, 1.8 ± 0.9 mg and 60 ± 4%, respectively, in the control state, and 3.7 ± 0.8 mg, 2.0 ± 0.7 mg and 56 ± 4%, respectively, during isoproterenol infusion. No significant changes in ED50, Emax and the dose of adenosine yielding AV nodal Wenckebach block could be demonstrated between the control state and during isoproterenol infusion. Thus, the negative dromotropic effects of adenosine on AV nodal conduction remained unchanged with β-adrenergic stimulation. These findings suggest that adenosine may remain efficacious in terminating catecholamine-sensitive supraventricular tachycardia involving the AV node as part of the reentrant circuit.

Original languageEnglish
Pages (from-to)1427-1431
Number of pages5
JournalThe American Journal of Cardiology
Volume70
Issue number18
DOIs
Publication statusPublished - 1992 Dec 1

Fingerprint

Isoproterenol
Adrenergic Agents
Adenosine
Atrioventricular Node
Supraventricular Tachycardia
Atrioventricular Block
Intravenous Injections
Acetylcholine
Catecholamines
Potassium

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{0321e6af004249f39ef59101ac68422e,
title = "Negative dromotropism of adenosine under beta-adrenergic stimulation with isoproterenol",
abstract = "Adenosine depresses atrioventricular (AV) nodal function by binding to specific A1 receptors which activate the acetylcholine, adenosine-regulated potassium current. In addition, adenosine can act to antagonize the effects of β-adrenergic stimulation on AV nodal function. To assess the negative dromotropic effects of adenosine under β-adrenergic stimulation, 15 patients were studied during clinical electrophysiologic study. During high right atrial pacing at a cycle length of 400 to 600 ms, adenosine was injected intravenously at an initial dose of 0.5 mg followed by a stepwise increment of 0.5 or 1.0 mg given at 5-minute intervals until a maximal dose of 12 mg was achieved or AV block developed. Intravenous isoproterenol (1 to 3 μg/min) was then infused to accelerate sinus rate by 20 to 30{\%} during which intravenous injection of incremental doses of adenosine as described was repeated. The AV nodal conduction time (AH interval) was measured at each dose of adenosine. Dose-response curves of AV nodal conduction time (expressed as percent increase in AH interval) were studied during the control state and during isoproterenol infusion. The dose of adenosine required to produce AV nodal Wenckebach block, the increase in the AH interval by 50{\%} (ED50) and the maximal response (Emax) were 3.4 ± 0.9 mg, 1.8 ± 0.9 mg and 60 ± 4{\%}, respectively, in the control state, and 3.7 ± 0.8 mg, 2.0 ± 0.7 mg and 56 ± 4{\%}, respectively, during isoproterenol infusion. No significant changes in ED50, Emax and the dose of adenosine yielding AV nodal Wenckebach block could be demonstrated between the control state and during isoproterenol infusion. Thus, the negative dromotropic effects of adenosine on AV nodal conduction remained unchanged with β-adrenergic stimulation. These findings suggest that adenosine may remain efficacious in terminating catecholamine-sensitive supraventricular tachycardia involving the AV node as part of the reentrant circuit.",
author = "Lai, {Wen Ter} and Sheng-Nan Wu and Sung, {Ruey J.}",
year = "1992",
month = "12",
day = "1",
doi = "10.1016/0002-9149(92)90294-9",
language = "English",
volume = "70",
pages = "1427--1431",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "18",

}

Negative dromotropism of adenosine under beta-adrenergic stimulation with isoproterenol. / Lai, Wen Ter; Wu, Sheng-Nan; Sung, Ruey J.

In: The American Journal of Cardiology, Vol. 70, No. 18, 01.12.1992, p. 1427-1431.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Negative dromotropism of adenosine under beta-adrenergic stimulation with isoproterenol

AU - Lai, Wen Ter

AU - Wu, Sheng-Nan

AU - Sung, Ruey J.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - Adenosine depresses atrioventricular (AV) nodal function by binding to specific A1 receptors which activate the acetylcholine, adenosine-regulated potassium current. In addition, adenosine can act to antagonize the effects of β-adrenergic stimulation on AV nodal function. To assess the negative dromotropic effects of adenosine under β-adrenergic stimulation, 15 patients were studied during clinical electrophysiologic study. During high right atrial pacing at a cycle length of 400 to 600 ms, adenosine was injected intravenously at an initial dose of 0.5 mg followed by a stepwise increment of 0.5 or 1.0 mg given at 5-minute intervals until a maximal dose of 12 mg was achieved or AV block developed. Intravenous isoproterenol (1 to 3 μg/min) was then infused to accelerate sinus rate by 20 to 30% during which intravenous injection of incremental doses of adenosine as described was repeated. The AV nodal conduction time (AH interval) was measured at each dose of adenosine. Dose-response curves of AV nodal conduction time (expressed as percent increase in AH interval) were studied during the control state and during isoproterenol infusion. The dose of adenosine required to produce AV nodal Wenckebach block, the increase in the AH interval by 50% (ED50) and the maximal response (Emax) were 3.4 ± 0.9 mg, 1.8 ± 0.9 mg and 60 ± 4%, respectively, in the control state, and 3.7 ± 0.8 mg, 2.0 ± 0.7 mg and 56 ± 4%, respectively, during isoproterenol infusion. No significant changes in ED50, Emax and the dose of adenosine yielding AV nodal Wenckebach block could be demonstrated between the control state and during isoproterenol infusion. Thus, the negative dromotropic effects of adenosine on AV nodal conduction remained unchanged with β-adrenergic stimulation. These findings suggest that adenosine may remain efficacious in terminating catecholamine-sensitive supraventricular tachycardia involving the AV node as part of the reentrant circuit.

AB - Adenosine depresses atrioventricular (AV) nodal function by binding to specific A1 receptors which activate the acetylcholine, adenosine-regulated potassium current. In addition, adenosine can act to antagonize the effects of β-adrenergic stimulation on AV nodal function. To assess the negative dromotropic effects of adenosine under β-adrenergic stimulation, 15 patients were studied during clinical electrophysiologic study. During high right atrial pacing at a cycle length of 400 to 600 ms, adenosine was injected intravenously at an initial dose of 0.5 mg followed by a stepwise increment of 0.5 or 1.0 mg given at 5-minute intervals until a maximal dose of 12 mg was achieved or AV block developed. Intravenous isoproterenol (1 to 3 μg/min) was then infused to accelerate sinus rate by 20 to 30% during which intravenous injection of incremental doses of adenosine as described was repeated. The AV nodal conduction time (AH interval) was measured at each dose of adenosine. Dose-response curves of AV nodal conduction time (expressed as percent increase in AH interval) were studied during the control state and during isoproterenol infusion. The dose of adenosine required to produce AV nodal Wenckebach block, the increase in the AH interval by 50% (ED50) and the maximal response (Emax) were 3.4 ± 0.9 mg, 1.8 ± 0.9 mg and 60 ± 4%, respectively, in the control state, and 3.7 ± 0.8 mg, 2.0 ± 0.7 mg and 56 ± 4%, respectively, during isoproterenol infusion. No significant changes in ED50, Emax and the dose of adenosine yielding AV nodal Wenckebach block could be demonstrated between the control state and during isoproterenol infusion. Thus, the negative dromotropic effects of adenosine on AV nodal conduction remained unchanged with β-adrenergic stimulation. These findings suggest that adenosine may remain efficacious in terminating catecholamine-sensitive supraventricular tachycardia involving the AV node as part of the reentrant circuit.

UR - http://www.scopus.com/inward/record.url?scp=0026476122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026476122&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(92)90294-9

DO - 10.1016/0002-9149(92)90294-9

M3 - Article

VL - 70

SP - 1427

EP - 1431

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 18

ER -